New York, New York - 10/02/2012
Attitude Drinks Inc (NDA) (OTC: ATTD) among the gainers and the stock soared 28.57% to $0.0009 on a traded volume of 8.51 million shares. The 52-week range for the stock is $5.80 and $31.66. The Company has Price/Sales ratio of 1.99. The organization is a development-stage company. The Company focuses on the non-alcoholic single serving beverage business, developing and marketing of milk based products.
Will ATTD Continue To Move Higher After Today’s Sudden Buying Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=ATTD
Advanced Cell Technology Inc (OTC: ACTC) decreased 2.24% to $0.0742 on a traded volume of 4.63 million shares. The chief scientific officer of the Company, Robert Lanza, M.D. and Anthony Atala, M.D., W.H. Boyce Professor and Director of the Wake Forest Institute for Regenerative Medicine have released the second edition of Handbook of Stem Cells.
How Should Investors Trade ACTC After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=ACTC
Medisafe 1 Technologies Corp (OTC: MFTH) is currently trading at $0.0053 on a traded volume of 2.28 million shares. The company's common stock became eligible for trading on the Berlin Stock Exchange, under the symbol "MS1" and the German security number “A1JPAQ".
The Company plans to issue a one-time special dividend to all existing shareholders pending the perpetual license sale of technology rights to a third party.
Don’t Miss Any Updates on MFTH & Get Free News Alert In Your Inbox by Signing Up Here http://beststocksdaily.com/p2/index.php?company=MFTH
eLayaway Inc (OTC: ELAY) is currently trading at $0.0040 on a traded volume of 1.99 million shares. So far this year, the stock is down over 81%. The 52-week range for the stock is $0.0 and $0.16. The firm is a technology company that specialize in the payment’s industry, for both online and bricks and mortar merchants.
Get Free Special Trend Analysis On ELAY Here http://beststocksdaily.com/p2/index.php?company=ELAY
AMARANTUS BIOSCIENCES INC (OTC: AMBS) is currently trading at $0.0080 on a traded volume of 2.83 million shares. The stock opened at $0.01. Recently, the Company announced the U.S. FDA has acknowledged receipt of the New Drug Application resubmission for ELIQUIS to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The FDA assigned a new Prescription Drug User Fee Act goal date of March 17, 2013.
Get Free Special Trend Analysis On AMBS Here http://beststocksdaily.com/p2/index.php?company=AMBS
1419 Westwood Blvd Los Angeles, CA